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Aims: 
The purpose of this study is to develop and test the psychometrics of a self-report version of 
a measure of the capacity of addiction and mental health programs to deliver dual-diagnosis 
treatment, that is, to provide treatment for both addiction problems and mental health 
problems.  Traditionally these services are provided by very different service providers that 
did not until recently interact very well, if at all.  The increasing recognition that patients 
who suffer from both kinds of problems – who are dually diagnosed – would benefit from 
integrated delivery of addiction and mental health services has led to efforts to encourage 
provision of such integrated services in programs that have tended to focus primarily on 
the delivery of either addiction or mental health services to the exclusion of the other.  In 
order to assess how well the integration of these services is progressing, various measures 
have been developed, one of which is the original Dual Diagnosis Capability in Addiction 
Treatment (DDCAT) Index.  The DDCAT, as it now stands, however, is a very time-intensive 
tool.  It requires a rater to visit a site and spend one half to a full day there interviewing 
administrators, therapists, and patients, reviewing medical records, and attending meetings. 
The purpose of this study is to test a self-report version of the DDCAT that will be administered 
to administrators and therapists to see how well it performs compared to the more time-
intensive procedures of the original DDCAT.
Methods:  
A preliminary version of a self-report measure titled, the Co-occurring Disorders Program 
Brief Screening Tool (CODP-BST) was developed, consisting of 35-49 items, 25-39 Yes/No 
questions, and 10 questions with Likert-like responses.  This version was sent to several 
experts in the field who had agreed to provide feedback on the questions regarding the 
importance and relevance of each one, as well as provide written concerns, comments, 
and suggestions for each one.  Completed responses were received from 11 experts.  We 
are in the process of rewriting some of the questions and adding about 35 more in order 
to let the CODP-BST parallel the questions rated on the DDCAT as much as possible.  We 
are in the process of training raters to administer the DDCAT to programs in addiction and 
mental health around the state, where we will also ask administrators and clinicians in the 
programs to complete the CODP-BST.  That way we will be able to examine the reliability, 
factor structure, and validity of the CODP-BST.
Results:.  
The results of the experts’ ratings of the importance of each question on the CODP-BST was 
encouraging.  Items could be rated 0 = unimportant/irrelevant; 1 = mostly unimportant/
irrelevant; 2 = somewhat important/relevant; 3 = very important/relevant; or 4 = Crucial. 
No question was rated lower than a 2.  The average ratings on the questions ranged from 
2.18 to 4.00.  The average rating for all of the questions was 3.06 (sd = 0.45), indicating 
that on average the experts thought the questions were very relevant and important. 
Only 9 items (18%) averaged lower than 2.75, and of these only 6 (12% of the total scale) 
averaged 2.18 to 2.40.
Discussion:  
We are hopeful that over the next 8-10 months we will be able to complete the revision 
of the CODP-BST and collect ample evidence of the reliability and validity of our new self-
report measure.  Such a measure will provide a powerful tool for addiction and mental 
health programs to assess their own current capacity to provide integrated treatment for 
co-occurring addiction and mental health disorders and allow them to determine where 
their strengths lie and where they might mostly effectively concentrate their efforts to 
improve their co-occurring disorder treatment services.
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III. CLINICAL 
PROCESS: 
ASSESMENT
IIIC: Psychiatric 
and substance use 
diagnoses made 
and documented.
Psychiatric 
diagnoses are not 
made or recorded.
Off site MH 
professional may 
make diagnosis, 
and then is 
recorded.
MH professional 
makes diagnosis, 
recorded in chart. 
(Variable).
Standard & routine 
diagnoses made by 
MH professional staff 
member.
IIID: Psychiatric 
and substance use 
history reflected in 
medical record.
Not present. Variable by 
individual clinician.
Routine 
documentation in 
record in narrative 
section.
Specific section in 
record devoted to 
history and chronology 
of course of both 
disorders.
IIIE: Service 
matching based 
on psychiatric 
symptom acuity: 
low, moderate, high.
Can provide care to 
persons with no to 
low acuity.
Can provide care to 
persons with low to 
moderate acuity, but 
who are primarily 
stable.
Can provide care to 
persons with moderate 
to high acuity, including 
those unstable in their 
psychiatric condition.
DDCAT Example
Contact Information
Kenneth E. Fletcher, Ph.D.
Email : kenneth.fletcher@umassmed.edu
Tara Zandi, B.S.
Email: tara.zandi@umassmed.edu
Development of  a Self-report Measure of  Dual Diagnosis 
Capability for Addiction and Mental Health Programs
Kenneth E. Fletcher, Ph.D., Anna Kline, Ph.D., Tara Zandi, B.S., Gregory Seward, MSHCA, LADC-I, Sun Kim, Ph.D., A.P.R.N., Douglas M. Ziedonis, M.D., M.P.H.
Please check each of the following questions Yes, No, or Not Applicable (N/A) or Not Sure (NS): 
Yes No 
N/A 
or 
NS 
3. Prior to or at admission, does your program screen for addiction problems?   
3a. If yes, does your program use a standardized addiction screening instrument?    
     If yes, which one: _________________________________________________ 
4. Prior to or at admission, does your program screen for mental health problems?   
4a. If yes, does your program use a standardized mental health screening instrument?    
     If yes, which one: _________________________________________________ 
5. 
After admission, does your program conduct a comprehensive assessment for addiction prob-
lems?   
5a. If yes, does your program use the Addiction Severity Index, GAIN, or other standard-ized instrument?    
     If other, please specify: ____________________________________________ 
6. 
After admission, does your program conduct a comprehensive assessment for mental health 
problems?   
6a. 
If yes, does your program use a standardized instrument? 
   
     If yes, please specify which instrument is used: ______________________________________ 
Examples of CODP–BST
7. Is your program licensed to provide addiction treatment? 
8. Is your program licensed to provide mental health treatment? 
9. Is your program licensed or certified to provide treatment for co-occurring addiction and men-
tal health problems? 
10. Are you able to bill for addiction problems as a primary diagnosis? 
11. Are you able to bill for mental health problems as a primary diagnosis? 
12. Does your state have co-occurring disorder codes for billing? 
13. Are patients on psychiatric medications allowed into your program? 
14. Are patients on methadone allowed into your program? 
15. Does your program have collaborative relationships with other agencies who prescribe sub-
stance abuse or psychiatric medications for your patients? 
32. In the past year, what percent of your staff received professional training in substance abuse treatment? 
      (Check one:) 
None 
No more 
than 
10% 
About 10-25% About 25-50% About 50-75% About 75-100% 
      
33. In the past year, what percent of your staff received professional training in mental illness treatment? 
      (Check one:) 
None 
No more 
than 
10% 
About 10-25% About 25-50% About 50-75% About 75-100% 
      
34. In the past year, what percent of your staff received professional training in treatment for co-occurring 
      disorders?  (Check one:) 
None 
No more 
than 
10% 
About 10-25% About 25-50% About 50-75% About 75-100% 
      
35. On a scale of 0-10, how would you rate how well your program addresses co-occurring disorders? 
      (Check one:) 
0 1 2 3 4 5 6 7 8 9 10 
           
